Autopsy report · NCT00424489
Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis
Cause of deathSlow enrollment
“No participants enrolled for more than two years. No plan to continue study.”
Life of this trial
- Registered 4 years 11 months after it had already started.
- Ran for about 14 years 4 months before it stopped.
- 9 participants enrolled.
- Results were posted on the registry 2 years 2 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Northwestern University
- Sponsor type
- University, hospital or other
- Conditions
- Myasthenia Gravis
- Interventions
- Hematopoietic Stem Cell Transplantation; Cyclophosphamide; ATG (rabbit); Mesna; Methylprednisolone; G-CSF
- Participants
- 9
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Prospective Evaluation of a New Covered Metal Stent for Malignant Lesions of the Esophagus
“No participants enrolled for more than 1 year.” - Accelerated Intermittent Theta-Burst Stimulation for Opiate Use Disorder
“No participants enrolled. No longer continuing study.” - Mindfulness Training Versus Low (FODMAP) Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols Diet
“The study was withdrawn prior to initiation. No participants were enrolled.” - Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical Investigation
“Study did not begin, and no participants were enrolled.” - OMega-3 Fatty Acid for the Immune Modulation of Colorectal Cancer
“Study will be closed due to zero enrollment in over 2 years.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.